647921014	647921014	CD	B-NP	O
|	|	NN	I-NP	O
GAHC	GAHC	NN	I-NP	O
|	|	NN	I-NP	O
63125391	63125391	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2726736	2726736	CD	B-NP	O
|	|	CC	I-NP	O
6/21/2006	6/21/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/12/2006	4/12/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/22/2006	7/22/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
JINGST	JINGST	NNP	B-NP	O
,	,	,	O	O
TRACY	TRACY	NNP	B-NP	O
132-45-34-6	132-45-34-6	CD	I-NP	O
Quergrove	Quergrove	NNP	I-NP	O
H	H	NNP	I-NP	O
Prings	Prings	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/8/06	1/8/06	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KINKADE	KINKADE	NNP	B-NP	O
,	,	,	O	O
CAREY	CAREY	NNP	B-NP	O
ROCKY	ROCKY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECOTRIN	ECOTRIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
July	July	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
HODGDON	HODGDON	NN	B-NP	O
,	,	,	O	O
WES	WES	NNP	B-NP	O
A	A	NNP	I-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TRICOR	TRICOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
794703244	794703244	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	B-DNA
BACLOFEN	BACLOFEN	NN	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	I-DNA
CARBAMAZEPINE	CARBAMAZEPINE	NNP	I-NP	I-DNA
200	200	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
TRICOR	TRICOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRICOR	TRICOR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
48	48	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
DELISI	DELISI	NNP	B-NP	O
,	,	,	O	O
PERCY	PERCY	NNP	B-NP	O
O.	O.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QAM	QAM	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
SARGENT	SARGENT	NNP	B-NP	O
,	,	,	O	O
NUMBERS	NUMBERS	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	B-NP	O
100	100	CD	B-NP	O
or	or	CC	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Jacobitz	Jacobitz	NNP	I-NP	O
in	in	IN	B-PP	O
Sweeleigh	Sweeleigh	NNP	B-NP	O
Sondown	Sondown	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
504-194-0461	504-194-0461	CD	I-NP	O
Thurs	Thurs	NNP	I-NP	O
September	September	NNP	I-NP	O
at	at	IN	B-PP	O
2pm	2pm	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Vernon	Vernon	NNP	I-NP	O
Klaphake	Klaphake	NNP	I-NP	O
at	at	IN	B-PP	O
Ybrook	Ybrook	NNP	B-NP	O
Nursing	Nursing	NNP	I-NP	O
Home	Home	NNP	I-NP	O
-	-	HYPH	B-NP	O
call	call	NN	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
appointment	appointment	NN	B-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
wks	wk	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
dm	dm	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cva	cva	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
seizure	seizure	NN	I-NP	O
disorder	disorder	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
PE	PE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
left	left	JJ	B-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
s/p	s/p	NN	I-NP	O
PCI	PCI	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
microdriver	microdriver	NN	I-NP	O
stents	stent	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PLV	PLV	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
retrograde	retrograde	JJ	I-NP	O
limb	limb	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PLV	PLV	NN	I-NP	O
extending	extend	VBG	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
***	***	SYM	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
pt	pt	NN	B-NP	O
.	.	.	O	O

w	w	NN	B-NP	O
/	/	SYM	B-VP	O
known	know	VBN	B-NP	O
CAD	CAD	NN	I-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
+	+	SYM	O	O
PCI	PCI	NN	B-NP	O
's	's	POS	B-NP	O
***	***	SYM	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
74	74	CD	I-NP	O
yo	yo	NN	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
1998	1998	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
lima-lad	lima-lad	JJ	B-ADJP	O
,	,	,	O	O
svg-rca	svg-rca	NN	B-NP	O
,	,	,	O	O
svg-om1	svg-om1	NN	B-NP	O
,	,	,	O	O
svg-diag1	svg-diag1	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
with	with	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
PCI	PCI	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
svg-diag1	svg-diag1	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
11/3	11/3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
SVG-RCA	SVG-RCA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
5/27	5/27	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
both	both	CC	B-PP	O
with	with	IN	B-PP	O
bare	bare	JJ	B-NP	O
metal	metal	NN	I-NP	O
stents	stent	NNS	I-NP	O
,	,	,	O	O
CVA	CVA	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
reasonably	reasonably	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
with	with	IN	B-PP	O
ADLs	ADL	NNS	B-NP	B-protein
and	and	CC	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
chest	chest	JJ	B-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	B-ADJP	O
for	for	IN	B-PP	O
over	over	IN	B-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
.	.	.	O	O

experienced	experienced	JJ	B-NP	O
sharp	sharp	JJ	I-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
5/10	5/10	CD	I-NP	O
,	,	,	O	O
non-radiating	non-radiating	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
associated	associated	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
CP	CP	NN	I-NP	B-DNA
improved	improve	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
2	2	CD	B-NP	O
NTGN	NTGN	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
more	more	JJR	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
stuttering	stutter	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
relieved	relieve	VBN	B-VP	O
by	by	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
CHC	CHC	NN	B-NP	B-protein
for	for	IN	B-PP	O
furthter	furthter	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
last	last	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
cathterization	cathterization	NN	I-NP	O
in	in	IN	B-PP	O
1/13	1/13	CD	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
11/1	11/1	CD	I-NP	O
cath	cath	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
3	3	CD	I-NP	O
of	of	IN	I-NP	O
4	4	CD	I-NP	O
grafts	graft	NNS	I-NP	O
were	be	VBD	B-VP	O
patent	patent	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
SVG-OM	SVG-OM	NNP	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
complex	complex	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
.	.	.	O	O

's	's	POS	B-NP	O
last	last	JJ	I-NP	O
ECHO	ECHO	NN	I-NP	O
in	in	IN	B-PP	O
11/1	11/1	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
mild-mod	mild-mod	JJ	B-NP	O
MR.	MR.	NNP	I-NP	O
***	***	SYM	I-NP	O
ED	ED	NN	I-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
Afeb	Afeb	NN	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
68	68	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
128/69	128/69	CD	I-NP	I-DNA
,	,	,	O	O
O2sat	O2sat	NN	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

Enzymes	Enzyme	NNS	B-NP	B-protein
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
with	with	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
TW	TW	NNP	I-NP	O
flattening	flattening	NN	I-NP	O
.	.	.	O	O

CTA	CTA	NN	B-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
dissection	dissection	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
nitro	nitro	NN	B-NP	O
SL	SL	NN	I-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
2mg	2mg	NN	I-NP	O
x1	x1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
heparin	heparin	NN	I-NP	O
gtt	gtt	NN	I-NP	O
with	with	IN	B-PP	O
bolus	bolus	NN	B-NP	O
.	.	.	O	O

************	************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CVA	CVA	NN	I-NP	O
*	*	SYM	B-NP	O
PE	PE	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
previously	previously	RB	B-ADVP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
*	*	SYM	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
98	98	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LIMa	LIMa	NNP	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
LAD	LAD	NN	B-NP	O
,	,	,	O	O
SVG	SVG	NN	B-NP	O
--	--	:	O	O
>	>	SYM	O	O
RCA	RCA	NN	B-NP	B-protein
,	,	,	O	O
SVG	SVG	NN	B-NP	O
--	--	:	O	O
>	>	SYM	O	O
OM	OM	NN	B-NP	O
,	,	,	O	O
SVG	SVG	NN	B-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
diag	diag	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
PCI	PCI	NN	I-NP	O
+	+	SYM	B-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
SVG	SVG	NN	B-NP	O
--	--	:	O	O
>	>	SYM	O	O
dig	dig	NN	B-NP	O
2002	2002	CD	I-NP	O
and	and	CC	I-NP	O
SVG	SVG	NN	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
RCA	RCA	NN	B-NP	O
2004	2004	CD	I-NP	O
.	.	.	O	O

SVG	SVG	NN	B-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
OM	OM	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
not	not	RB	B-VP	O
intervened	intervene	VBN	I-VP	O
upon	upon	IN	B-PP	O
*	*	SYM	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
EF	EF	NN	I-NP	B-protein
30	30	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
11/1	11/1	CD	B-NP	I-protein
*	*	SYM	I-NP	I-protein
HTN	HTN	NN	I-NP	I-protein
*	*	SYM	B-NP	O
GERD	GERD	NN	I-NP	O
*	*	SYM	I-NP	O
s/p	s/p	NN	I-NP	O
ccy	ccy	NN	I-NP	O
*	*	SYM	B-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
*	*	SYM	I-NP	O
DM	DM	NN	I-NP	O
***	***	SYM	B-NP	O
HOME	HOME	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
carbamazepine	carbamazepine	NN	B-NP	O
200mg	200mg	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	B-protein
40mg	40mg	NN	I-NP	I-protein
po	po	NN	I-NP	I-protein
daily	daily	RB	B-ADVP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
5mg	5mg	NN	I-NP	O
po	po	NN	I-NP	O
QAM	QAM	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
10mg	10mg	NN	I-NP	O
po	po	NN	I-NP	O
qam	qam	NN	I-NP	O
,	,	,	O	O
toprol	toprol	NN	B-NP	O
xl	xl	NN	I-NP	O
150mg	150mg	NN	I-NP	O
qam	qam	NN	I-NP	O
,	,	,	O	O
ecotrin	ecotrin	NN	B-NP	O
325	325	CD	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
plavix	plavix	NN	I-NP	O
75mg	75mg	NN	I-NP	O
qam	qam	NN	I-NP	O
,	,	,	O	O
prilosec	prilosec	NN	B-NP	O
40mg	40mg	NN	I-NP	O
qpm	qpm	NN	I-NP	O
,	,	,	O	O
tricor	tricor	NN	B-NP	O
48mg	48mg	NN	I-NP	O
qpm	qpm	NN	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
10mg	10mg	NN	I-NP	O
po	po	NN	I-NP	O
qpm	qpm	NN	I-NP	O
,	,	,	O	O
baclofen	baclofen	NN	B-NP	O
10mg	10mg	NN	I-NP	O
po	po	NN	I-NP	O
qpm	qpm	NN	I-NP	O
,	,	,	O	O
isosorbide	isosorbide	NN	B-NP	O
mononitrate	mononitrate	NN	I-NP	O
30mg	30mg	CD	I-NP	O
po	po	NN	I-NP	O
qpm	qpm	NN	I-NP	O
***	***	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
***	***	SYM	O	O
SH	SH	NN	B-NP	O
:	:	:	O	O
Widow	Widow	NN	B-NP	O
.	.	.	O	O

Wife	Wife	NNP	B-NP	O
died	die	VBD	B-VP	O
2	2	CD	B-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Quit	Quit	NNP	B-NP	O
smoking	smoke	VBG	B-VP	O
30	30	CD	B-NP	O
yrs	yr	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
etoh	etoh	NN	I-NP	O
.	.	.	O	O

***	***	SYM	O	O
ADMISSION	ADMISSION	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
afebrile	afebrile	JJ	B-NP	O
P	P	NN	I-NP	O
64	64	CD	I-NP	O
SBP	SBP	NN	I-NP	O
103	103	CD	B-NP	O
sat	sit	VBD	B-VP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
;	;	:	O	O
NAD	NAD	NN	B-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
+	+	SYM	I-NP	O
o	o	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
;	;	:	O	O
L	L	NN	B-NP	O
sided	sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
;	;	:	O	O
S1S2	S1S2	NN	B-NP	O
2/6	2/6	CD	I-NP	O
HSM	HSM	NN	I-NP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
,	,	,	O	O
ab	ab	VBP	B-VP	O
soft	soft	JJ	B-NP	B-protein
NTl	NTl	NN	I-NP	I-protein
ext	ext	IN	B-PP	I-protein
warm	warm	JJ	B-NP	I-protein
***	***	SYM	I-NP	I-protein
ADMISSION	ADMISSION	NN	I-NP	I-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
Cr	Cr	NN	B-NP	O
1.6	1.6	CD	I-NP	O
-LRB-	-LRB-	:	O	O
baseline	baseline	NN	B-NP	O
1.4	1.4	CD	I-NP	O
-RRB-	-RRB-	:	O	O
hct	hct	NN	B-NP	O
36.9	36.9	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
lipase	lipase	NN	B-NP	O
119	119	CD	I-NP	O
,	,	,	O	O
ddimer	ddimer	NN	B-NP	O
262	262	CD	I-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
260	260	CD	I-NP	I-protein
***	***	SYM	I-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CXR	CXR	NN	I-NP	B-protein
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
CP	CP	NN	I-NP	O
process	process	NN	I-NP	O
*	*	SYM	B-NP	O
CTA	CTA	NN	I-NP	B-protein
+	+	SYM	O	O
CT	CT	NN	B-NP	O
abd/pelvis	abd/pelvis	NN	I-NP	O
-	-	HYPH	O	O
official	official	JJ	B-NP	O
read	read	NN	I-NP	O
pending	pende	VBG	B-VP	O
;	;	:	O	O
prelim	prelim	JJ	B-NP	O
read	read	NN	I-NP	O
of	of	IN	B-PP	O
CTA	CTA	NN	B-NP	B-protein
describes	describe	VBZ	B-VP	O
sternotomy	sternotomy	NN	B-NP	O
clips	clip	NNS	I-NP	O
,	,	,	O	O
vascular	vascular	JJ	B-NP	O
calcification	calcification	NN	I-NP	O
,	,	,	O	O
non-specific	non-specific	JJ	B-NP	O
LN	LN	NN	I-NP	O
in	in	IN	B-PP	O
mediastinum	mediastinum	NN	B-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
dilation	dilation	NN	I-NP	O
of	of	IN	B-PP	O
trahepatic	trahepatic	JJ	B-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
L	L	NN	I-NP	O
>	>	SYM	B-NP	O
R	R	NN	I-NP	O
perinephric	perinephric	JJ	I-NP	O
stranding	stranding	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
hypodense	hypodense	NN	I-NP	O
kidney	kidney	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
diverticulosis	diverticulosis	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dissection	dissection	NN	I-NP	O
*	*	SYM	B-NP	O
EKG	EKG	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
nsr	nsr	NN	I-NP	B-protein
,	,	,	O	O
1st	1st	JJ	B-NP	O
degr	degr	NN	I-NP	O
avb	avb	NN	I-NP	O
,	,	,	O	O
ivcd	ivcd	NN	B-NP	O
L	L	NN	I-NP	O
bundaloid	bundaloid	NN	I-NP	O
,	,	,	O	O
qtc	qtc	NN	B-NP	B-DNA
416	416	CD	I-NP	I-DNA
,	,	,	I-NP	O
II	II	CD	I-NP	O
TWI	TWI	NN	I-NP	O
,	,	,	O	O
III	III	CD	B-NP	O
,	,	,	O	O
avF	avF	NN	B-NP	O
flattening	flattening	NN	I-NP	O
,	,	,	O	O
I	I	PRP	B-NP	O
+	+	VBP	B-VP	O
AvL	AvL	NN	B-NP	B-protein
+	+	SYM	B-VP	O
v5-6	v5-6	NN	B-NP	O
TWI	TWI	NN	I-NP	O
*	*	SYM	B-VP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
dom	dom	NN	I-NP	O
,	,	,	O	O
occlusion	occlusion	NN	B-NP	O
of	of	IN	B-PP	O
native	native	JJ	B-NP	O
vessels	vessel	NNS	I-NP	O
including	include	VBG	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
diag	diag	NN	B-NP	O
,	,	,	O	O
Lcx	Lcx	NN	B-NP	B-protein
,	,	,	O	O
RCA	RCA	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
PLV	PLV	NN	B-NP	B-protein
.	.	.	O	O

Patent	Patent	NN	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
.	.	.	O	O

Patent	Patent	NN	B-NP	O
stented	stente	VBD	B-VP	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
diag	diag	NN	B-NP	O
and	and	CC	I-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
.	.	.	O	O

Known	Know	VBN	B-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
SVG	SVG	NN	B-NP	B-protein
to	to	TO	B-PP	O
OM	OM	NN	B-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
ECHO	ECHO	NN	I-NP	O
:	:	:	O	O
prelim	prelim	JJ	B-NP	O
EF	EF	NN	I-NP	O
35-40	35-40	CD	B-NP	O
%	%	NN	I-NP	O
***	***	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
and	and	CC	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
+	+	SYM	B-VP	O
stents	stent	NNS	B-NP	O
to	to	TO	B-PP	O
2/4	2/4	CD	B-NP	O
grafts	graft	NNS	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

presented	present	VBN	B-VP	O
with	with	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
tricor	tricor	NN	B-NP	O
,	,	,	O	O
bb	bb	NN	B-NP	O
,	,	,	O	O
acei	acei	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hep	hep	NN	B-NP	O
gtt	gtt	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
cathterization	cathterization	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	IN	B-PP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
native	native	JJ	B-NP	O
3vd	3vd	NN	I-NP	O
,	,	,	O	O
3/4	3/4	CD	B-NP	O
patent	patent	NN	I-NP	O
grafts	graft	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
PLV	PLV	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
had	have	VBD	B-VP	O
overlapping	overlap	VBG	I-VP	O
stent	stent	JJ	B-ADJP	O
to	to	TO	B-PP	O
distal	distal	JJ	B-NP	O
RCA	RCA	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
integrillin	integrillin	NN	B-NP	B-protein
x	x	SYM	O	O
18	18	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
dyslipidemia	dyslipidemia	NN	B-NP	O
*	*	SYM	I-NP	O
Lipids	Lipid	NNS	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
TC	TC	NN	B-NP	B-protein
117	117	CD	I-NP	I-protein
,	,	,	O	O
HDL	HDL	NN	B-NP	B-DNA
32	32	CD	I-NP	I-DNA
,	,	,	O	O
LDL	LDL	NN	B-NP	B-protein
54	54	CD	I-NP	I-protein
,	,	,	O	O
Tri	Tri	NNP	B-NP	O
153	153	CD	I-NP	O
.	.	.	O	O

LDL	LDL	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

HDL	HDL	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
low	low	JJ	B-ADJP	O
despite	despite	IN	B-PP	O
tricor	tricor	NN	B-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
could	could	MD	B-VP	O
consider	consider	VB	I-VP	O
titrating	titrate	VBG	I-VP	O
up	up	RP	B-PRT	O
tricor	tricor	NN	B-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	JJ	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
and	and	CC	I-NP	O
CKs	CK	NNS	I-NP	B-protein
would	would	MD	B-VP	O
require	require	VB	I-VP	O
close	close	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
EF	EF	NN	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

appeared	appear	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
bb	bb	NN	I-NP	O
,	,	,	I-NP	O
acei	acei	NN	I-NP	O
,	,	,	I-NP	O
lasix	lasix	NN	I-NP	O
and	and	CC	I-NP	O
nitrate	nitrate	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
ECHO	ECHO	NN	I-NP	O
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
,	,	,	O	O
prelim	prelim	NN	B-NP	O
shows	show	VBZ	B-VP	O
EF	EF	NN	B-NP	O
35-40	35-40	CD	I-NP	O
%	%	NN	I-NP	O
*	*	SYM	B-NP	O
NSR	NSR	NN	I-NP	B-protein
*	*	SYM	I-NP	O
NEURO	NEURO	NN	I-NP	B-protein
:	:	:	O	O
*	*	SYM	B-NP	O
CVA	CVA	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
carbamazepine	carbamazepine	NN	B-NP	O
for	for	IN	B-PP	O
tingling	tingle	VBG	B-VP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
h/o	h/o	NN	I-NP	O
PE	PE	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
is	be	VBZ	B-VP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

Ddimer	Ddimer	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

CTA	CTA	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
central	central	JJ	I-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
was	be	VBD	B-VP	O
pursued	pursue	VBN	I-VP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
clinical	clinical	JJ	B-NP	O
hx	hx	NN	I-NP	O
and	and	CC	I-NP	O
exam	exam	NN	I-NP	O
not	not	RB	O	O
consistent	consistent	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

Abnormal	Abnormal	JJ	B-NP	O
lab	lab	NN	I-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
outpt	outpt	JJ	B-NP	O
f/u	f/u	NN	I-NP	O
.	.	.	O	O

Issue	Issue	NN	B-NP	O
of	of	IN	B-PP	O
ongoing	ongoing	JJ	B-NP	O
coumadin	coumadin	NN	I-NP	O
for	for	IN	B-PP	O
h/o	h/o	NN	B-NP	O
PE	PE	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
readdressed	readdresse	VBN	I-VP	O
on	on	IN	B-PP	O
outpt	outpt	JJ	B-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
*	*	SYM	B-NP	O
GERD	GERD	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
PPI	PPI	NN	B-NP	B-protein
*	*	SYM	I-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
*	*	SYM	B-NP	O
Inactive	Inactive	JJ	I-NP	O
*	*	SYM	I-NP	O
dilation	dilation	NN	I-NP	O
of	of	IN	B-PP	O
intrahepatic	intrahepatic	JJ	B-NP	O
bile	bile	NN	I-NP	O
ducts	duct	NNS	I-NP	O
*	*	SYM	B-NP	O
Incidentally	Incidentally	RB	B-VP	O
discovered	discover	VBN	I-VP	O
on	on	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
.	.	.	O	O

WIll	WIll	DT	B-NP	O
require	require	VBP	B-VP	O
outpt	outpt	JJ	B-NP	O
f/u	f/u	NN	I-NP	O
and	and	CC	O	O
perhaps	perhaps	RB	B-ADVP	O
reimaging	reimage	VBG	B-VP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CRI	CRI	NN	I-NP	B-protein
*	*	SYM	B-NP	I-protein
Cr	Cr	NN	I-NP	I-protein
improved	improve	VBN	B-VP	O
from	from	IN	B-PP	O
1.6	1.6	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
1.4	1.4	CD	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
received	receive	VBD	B-VP	O
mucomyst	mucomyst	NN	B-NP	O
and	and	CC	O	O
alkalinized	alkalinize	VBN	B-NP	O
fluid	fluid	NN	I-NP	O
pre	pre	NN	I-NP	O
_	_	NN	I-NP	O
+	+	SYM	B-NP	O
post	post	NN	I-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

Ab	Ab	NN	B-NP	O
imaging	imaging	NN	I-NP	O
incidentally	incidentally	RB	B-ADVP	O
revealed	reveal	VBD	B-VP	O
L	L	NN	B-NP	O
>	>	SYM	B-NP	O
R	R	NN	I-NP	O
perinephric	perinephric	JJ	I-NP	O
stranding	stranding	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
unclear	unclear	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
or	or	CC	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
kidney	kidney	NN	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
outpt	outpt	JJ	B-NP	O
f/u	f/u	NN	I-NP	O
and	and	CC	O	O
perhaps	perhaps	RB	B-VP	O
repeat	repeat	VB	I-VP	O
imaging	image	VBG	I-VP	O
ONC	ONC	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
med	me	VBN	I-NP	O
LN	LN	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
hypodense	hypodense	NN	I-NP	O
kidney	kidney	NN	I-NP	O
lesion	lesion	NN	I-NP	O
*	*	SYM	B-NP	O
Incidental	Incidental	JJ	I-NP	O
finding	finding	NN	I-NP	O
on	on	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
outpt	outpt	JJ	B-NP	O
f/u	f/u	NN	I-NP	O
and	and	CC	O	O
possibly	possibly	RB	B-ADVP	O
repeat	repeat	NN	B-NP	O
imaging	imaging	NN	I-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
*	*	SYM	B-NP	O
anemia	anemia	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

's	's	POS	B-NP	O
hct	hct	NN	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
37	37	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
33	33	CD	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
oupt	oupt	JJ	B-NP	O
f/u	f/u	NN	I-NP	O
for	for	IN	B-PP	O
anemia	anemia	NN	B-NP	O
+	+	CC	B-NP	O
possible	possible	JJ	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
*	*	SYM	B-NP	O
DM	DM	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

's	's	POS	B-NP	O
glipizide	glipizide	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
novolog	novolog	NN	B-NP	O
while	while	IN	B-SBAR	O
hospitalized	hospitalize	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
glypizide	glypizide	NN	I-NP	O
.	.	.	O	O

PROPH	PROPH	NN	B-NP	O
:	:	:	O	O
hep	hep	NN	B-NP	O
gtt/nexium	gtt/nexium	NN	I-NP	O
***	***	SYM	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Exam	Exam	NN	B-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
save	save	NN	I-NP	O
for	for	IN	B-PP	O
new	new	JJ	B-NP	O
mild	mild	JJ	I-NP	O
bruising	bruise	VBG	I-NP	O
R	R	NN	I-NP	O
groin	groin	NN	I-NP	O
.	.	.	O	O

R	R	NN	B-NP	B-protein
LE	LE	NN	I-NP	I-protein
warm	warm	JJ	I-NP	I-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	I-protein
R	R	NN	I-NP	I-protein
pulses	pulse	VBZ	B-VP	O
dopplerable	dopplerable	JJ	B-ADJP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
hct	hct	NN	B-NP	O
33	33	CD	I-NP	O
,	,	,	O	O
Cr	Cr	NN	B-NP	O
1.5	1.5	CD	I-NP	O
***	***	SYM	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
without	without	IN	B-PP	O
services	service	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
and	and	CC	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
TO	TO	NN	B-NP	O
PT	PT	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
You	You	PRP	B-NP	B-protein
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
blockage	blockage	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
arteries	artery	NNS	I-NP	O
around	around	IN	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
blockage	blockage	NN	I-NP	O
was	be	VBD	B-VP	O
preventing	prevent	VBG	I-VP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
from	from	IN	B-PP	O
getting	get	VBG	B-VP	O
enough	enough	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
to	to	TO	I-VP	O
keep	keep	VB	I-VP	O
this	this	DT	B-NP	O
blocked	block	VBN	I-NP	O
artery	artery	NN	I-NP	O
open	open	JJ	B-ADJP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
take	take	VB	I-VP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
doctors	doctor	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Return	Return	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
or	or	CC	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
PCP/cards	PCP/card	NNS	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
F/u	F/u	NN	I-NP	O
official	official	JJ	I-NP	O
read	read	NN	I-NP	O
of	of	IN	B-PP	O
ECHo	ECHo	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
f/u	f/u	NN	I-NP	O
official	official	JJ	I-NP	O
read	read	NN	I-NP	O
of	of	IN	B-PP	O
CTA	CTA	NN	B-NP	B-protein
+	+	CC	I-NP	O
ab/pelv	ab/pelv	NN	I-NP	O
CT	CT	NN	I-NP	O
consider	consider	VBP	B-VP	O
repeat	repeat	NN	B-NP	O
imaging	imaging	NN	I-NP	O
to	to	TO	B-PP	O
eval	eval	NN	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
including	include	VBG	B-PP	O
nonspecific	nonspecific	JJ	B-NP	O
mediastinal	mediastinal	JJ	I-NP	O
LN	LN	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
dilation	dilation	NN	I-NP	O
of	of	IN	B-PP	O
intrahepatic	intrahepatic	JJ	B-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
>	>	SYM	B-VP	O
R	R	NN	B-NP	O
perinephric	perinephric	JJ	I-NP	O
stranding	stranding	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypodense	hypodense	NN	B-NP	O
L	L	NN	I-NP	O
kidney	kidney	NN	I-NP	O
lesion	lesion	NN	I-NP	O
-	-	HYPH	B-NP	O
Consider	Consider	NN	I-NP	O
repeat	repeat	NN	I-NP	O
ddimer	ddimer	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
abnormal	abnormal	JJ	B-ADJP	O
here	here	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
low	low	JJ	B-NP	O
prob	prob	NN	I-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
central	central	JJ	I-NP	O
PE	PE	NN	I-NP	O
on	on	IN	B-PP	O
CTA	CTA	NN	B-NP	B-protein
-RRB-	-RRB-	SYM	B-NP	O
-	-	HYPH	B-NP	O
Consider	Consider	NN	I-NP	O
repeat	repeat	NN	I-NP	O
lipase	lipase	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
abnormal	abnormal	JJ	B-ADJP	O
here	here	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
-RRB-	-RRB-	SYM	O	O
-	-	HYPH	O	O
f/u	f/u	NN	B-NP	O
anemia	anemia	NN	I-NP	O
and	and	CC	O	O
consider	consider	VB	B-VP	O
colonoscopy	colonoscopy	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BEAUGARD	BEAUGARD	NNP	B-NP	O
,	,	,	O	O
MONTE	MONTE	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ZT35	ZT35	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/8/06	1/8/06	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

